Who founded Minoryx Therapeutics?

Minoryx Therapeutics was founded by Marc Martinell.

Who are Minoryx Therapeutics's investors?

Minoryx Therapeutics's investors include Chiesi Ventures, Criteria Bio Ventures, Fund+, Invivo Capital Partners, Kurma Partners, Roche Venture Fund, Ysios Capital, Columbus Venture Partners and 4 more.

Where is Minoryx Therapeutics headquartered?

Minoryx Therapeutics is headquartered in Mataró, ES.

Minoryx Therapeutics

Mataró, ES · 15 known investors

Find your way into Minoryx Therapeutics

Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Marc MartinellCo-Founder & Chief Executive Officer

Investors · 15

Chiesi Ventureslisted by Chiesi VenturesBoston · $5M

How we know: Chiesi Ventures's portfolio page · globalgenes.org · Not right? Tell us

Criteria Bio Ventureslisted by Criteria Bio VenturesBarcelona

Fund+listed by Fund+Leuven · $5.5M – $16.5M

How we know: globalgenes.org · Not right? Tell us

Invivo Capital Partnerslisted by Invivo Capital PartnersBarcelona · $2.2M – $4.3M

Kurma Partnerslisted by Kurma PartnersParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · a partner's Signal profile · globalgenes.org · the VCSheet dataset · Not right? Tell us

Roche Venture Fundlisted by Roche Venture FundBasel · $648K – $3.2M

How we know: Roche Venture Fund's portfolio page · a partner's Signal profile · globalgenes.org · Not right? Tell us

Ysios Capitallisted by Ysios CapitalBarcelona · $5.4M – $21.6M

How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · globalgenes.org · the VCSheet dataset · Not right? Tell us

Columbus Venture PartnersreportedValenciavia Jose Mesa · inferred

How we know: funding news · the VCSheet dataset · Not right? Tell us

FaberreportedLisbon · $108K – $2.7M

How we know: a partner's Signal profile · Not right? Tell us

HealthequityreportedBarcelona

How we know: globalgenes.org · Not right? Tell us

Idinvest Partnersreported

How we know: globalgenes.org · Not right? Tell us

SambrinvestreportedCharleroi

How we know: globalgenes.org · Not right? Tell us

Also in the syndicate · 3

Caixa Capital RiscS.R.I.W.SFPI-FPIM

Funding

SEC filings, press & company announcements

Undisclosed amountseries BSep 2018
Fund+ (lead), Caixa Capital Risc, Chiesi Ventures, HealthEquity, Idinvest Partners, Kurma Partners, Roche Venture Fund, S.R.I.W., Sambrinvest, SFPI-FPIM, Ysios Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Minoryx Therapeutics do?: Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.
Who founded Minoryx Therapeutics?: Minoryx Therapeutics was founded by Marc Martinell.
Who are Minoryx Therapeutics's investors?: Minoryx Therapeutics's investors include Chiesi Ventures, Criteria Bio Ventures, Fund+, Invivo Capital Partners, Kurma Partners, Roche Venture Fund, Ysios Capital, Columbus Venture Partners and 4 more.
Where is Minoryx Therapeutics headquartered?: Minoryx Therapeutics is headquartered in Mataró, ES.